When taken together with anti-hypertensive drugs, folic acid supplements can help reduce the risk of stroke.
The authors of a study on cardiovascular health in China warn of a looming epidemic of heart disease.
Stress manifests itself in physical symptoms more often than we would like.
Luye Pharma strengthens its position in China's cardiovascular drug market with the US$600 million acquisition of Beijing Jialin Pharmaceutical.
Study shows that daily incense use is associated with a higher mortality rate due to cardiovascular disease.
If replicated in humans, the finding that heart cells have the capacity to divide long after birth could lead to regenerative treatments for heart disease.
Understanding how polar bears adapted to their high-fat diets could lead to new ways of preventing fatty plaques and treating cardiovascular disease.
Tianjin Medical University and Astrazeneca will collaborate to develop soluble epoxide hydrolase inhibitors for the treatment of cardiac fibrosis.
AstraZeneca and the Shanghai Institutes of Biological Sciences have signed an agreement to collaborate in cardiovascular disease research.